L2M – UTI Diagnostics Market Research

Urinary tract infections (UTIs) are one of the most common bacterial infections globally, affecting millions of people each year. The inappropriate use of antibiotics for UTIs is a significant driver of antibiotic resistance, posing a grave threat to public health. Complicated UTIs, characterized by treatment failure, recurrent infections, and increased mortality, disproportionately affect vulnerable populations, including older adults and individuals with neurogenic bladder conditions.

This project seeks to address these critical issues by conducting comprehensive research and developing innovative solutions. The project’s key objectives are to uncover the challenges experienced by healthcare providers, patients, and laboratory professionals in the UTI diagnostic process and to analyze the healthcare infrastructure, regulatory framework, and access disparities in North America concerning UTI diagnosis and treatment.

Faculty Supervisor:

Joseph Ferenbok

Student:

Partner:

Springboard Atlantic Inc.

Discipline:

Life Sciences

Sector:

Biotechnology

University:

University of Toronto

Program: